Stuart Therapeutics Completes Phase III Study of ST-100 for Dry Eye Disease, Topline Data Expected in February 2025

Stuart Therapeutics, Inc. (Stuart), a clinical-stage drug platform company developing novel therapies for ophthalmic diseases,  announced last patient...

January 23, 2025 | Thursday | News
Partner Therapeutics Partners with BARDA to Fund Phase 2 Study of LEUKINE in Sepsis Patients

Partner Therapeutics, Inc. (PTx) announced a collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administrat...

January 10, 2025 | Friday | News
Veralox Therapeutics Acquires Nudge Therapeutics to Advance Preclinical cGAS Inhibitor Compounds

 Veralox Therapeutics, a clinical-stage biotechnology company developing a new class of therapies targeting the 12-lipoxygenase (12-LOX) pathway, anno...

January 10, 2025 | Friday | News
Amarna Therapeutics Forms Strategic Partnership with NorthX Biologics to Advance Gene Therapy Development

Amarna Therapeutics, (“Amarna” or “the Company”), a privately held biotechnology company specializing in transformative gene therap...

December 04, 2024 | Wednesday | News
MGI Tech and Universidad de San Martín de Porres Forge Alliance to Advance Genetic Research in Peru

MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, announced a partnership with...

December 02, 2024 | Monday | News
Taiwan’s Formosa Pharmaceuticals Partners with Medvisis to Launch Innovative Ophthalmic Treatment in Switzerland and Liechtenstein

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Medvisis Switze...

November 29, 2024 | Friday | News
Bio-Rad Advances Oncology Diagnostics with IVDR Certification for CML Assay and Strategic Collaborations in MRD and ctDNA Detection

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced updates on its onco...

November 13, 2024 | Wednesday | News
AbbVie and Gedeon Richter Forge New Agreement to Explore Treatments for Neuropsychiatric Disorders

 AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') announced a new discovery, co-development and license agreement to advance novel targets for ...

October 25, 2024 | Friday | News
Maximize Time for Innovation: Strategies for Reducing Non-Core Tasks in the Lab

  Yet, many scientists find their days consumed by non-core tasks such as reagent preparation, instrument setup, and consumables management. These ...

August 09, 2024 | Friday | Product Spotlight
Extractables in single-use systems used in ADC manufacturing

Single‑use (SU) systems have great potential for use in antibody‑drug conjugate (ADC) manufacturing. The use of organic solvents in the ADC process m...

June 19, 2024 | Wednesday | Product Spotlight
Empower the Next Wave of Pharmaceutical Breakthroughs with Molecule GEN's AI-Driven Innovation

Molecule GEN The process of drug discovery for bringing a new drug from the lab to the market often takes upwards of ten years and costs billions of dolla...

February 13, 2024 | Tuesday | Product Spotlight
Unleash the Future of Drug Discovery with Molecule GEN: Your AI Odyssey Begins Here!

In the fast-paced realm of drug discovery, Molecule GEN stands as a beacon of innovation, promising a quantum leap in the way we approach pharmaceutical br...

December 03, 2023 | Sunday | News
Three Ways Chromatography Data System Software Drives the Lab of the Future

CDS software serves as the primary interface for lab analysts, making user interface and user experience important considerations when being developed. Add...

October 23, 2023 | Monday | News
Industry 4.0 for USP 467: Unlocking Lab Productivity Potential

In today’s evolving industrial landscape, the concept of Industry 4.0 is revolutionizing various sectors by leveraging digitalization and automation ...

September 26, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close